Here are some more key details from the report:
- Notable developments in the global ENT device market include Stryker’s acquisition of Entellus Medical, Johnson & Johnson’s Acclarent in collaboration with Bioscience Webster and Olympus Corporation’s launch of a rhino-laryngo videoscope, all in 2018.
- Other developments include Intersect ENT’s FDA approval of a sinus implant in 2017 and Carl Zeiss Meditech AG’s launch of devices to improve workflow for ENT procedures in 2018.
- The rise in ENT disorders, especially among children, is expected to be a key driver in the market for devices. This may also lead to more reimbursement support to patients.
- More people are preferring minimally invasive surgeries, which is expected to drive developments in medical technologies.
Read the full release and access the reports here.
More articles on surgery centers:
10 recent ASC leadership moves
Virginia ASC takes infection prevention to new level — 3 insights
Surgery Partners goes all-in on cardiology — 5 quotes on its quarterly performance
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
